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Purpose: There are few genetic studies and clinical descriptions of Asian patients with X-linked ocular albinism (OA1).
In the present study, the mutation analysis of G protein-coupled receptor 143 gene (GPR143) and clinical characteristics
were assessed in Chinese patients with OA1.
Methods: Six families with OA1 were recruited from our pediatric and genetic eye clinic. Genomic DNA was prepared
from venous leukocytes. The coding regions of GPR143 were amplified by polymerase chain reaction, and subsequently
analyzed by direct sequencing. The variations detected were further evaluated in available family members as well as
controls.
Results:  Mutations  in  GPR143  were  identified  in  each  of  the  six  families:  c.849delT  (p.Val284SerfsX15);  c.
238_240delCTC  (p.Leu80del);  c.658+1G>A,  c.353G>A  (p.Gly118Glu);  g.1103_7266del6164  (p.Gly84AlafsX65),
which resulted in a deletion of exons 2 and 3; and g.25985_26546del562 (p.Gly296ValfsX26), which resulted in a deletion
of exon 8. Of these six, c.353G>A is a known mutation, while the other five are novel. All affected patients had nystagmus,
poor visual acuity, and foveal hypoplasia. However, hypopigmentation of the iris and fundus was very mild in these
patients.
Conclusions: Five novel mutations and one known mutation were identified in six Chinese families with OA1. These
results expand the mutation spectrum of GPR143, and demonstrate the clinical characteristics of OA1 among the Chinese.
X-linked ocular albinism (OA1; OMIM 300500), also
called ocular albinism type 1, is the most common form of
ocular  albinism.  Most  affected  white  males  exhibit
nystagmus,  poor  visual  acuity,  iris  translucency,  foveal
hypoplasia, an albinotic fundus, and normally pigmented skin
and  hair  [1-4].  Other  findings  may  include  photophobia,
strabismus, and misrouting of the optic tracts, resulting in loss
of stereoscopic vision [5-7]. In some OA1 patients of black
people, O'Donnell found hypopigmentation of the iris and
retina  may  be  subtle,  such  that  these  patients  present  a
nonalbinotic fundus and little iris translucency [8]. However,
the characteristics of OA1 have not been well defined in
Asians. The misdiagnosis of OA1 as congenital nystagmus is
not  uncommon,  and  is  usually  due  to  lack  of  clinical
experience or lack of phenotypic characterization for certain
ethnic groups [9-14]. Such misdiagnoses might have gone
undetected before the OA1 gene was identified.
OA1 is caused by mutations in the G protein-coupled
receptor 143 (GPR143) gene (OMIM 300500), originally also
known as the OA1 gene, located at Xp22.32 [15-17]. Various
types  of  mutations  in  GPR143  have  been  identified  in
Caucasians living in the Netherlands, the United Kingdom,
the United States, Germany, Canada, Belgium, France, Italy,
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and South Africa (albinism). Interestingly, genetic studies of
Chinese patients with OA1 are rare.
In this study, sequence analysis of GPR143 resulted in
the identification of mutations in each family, including five
novel and one known mutations. Furthermore, we describe the
clinical characteristics of OA1 patients and female carriers
from six Chinese families.
METHODS
Patients: There are 15 patients and 7 carriers participated in
this study (Figure 1, Table 1), further more, 100 normal male
controls mainly from the South of China also take part in, all
these people are collected by our Pediatric and Genetic Clinic
of  Zhongshan  Ophthalmic  Center.  Informed  consent
conforming to the tenets of the Declaration of Helsinki was
obtained from each participant before the study. Medical and
ophthalmic  histories  were  obtained.  Ophthalmological
examination including visual acuity assessment , slit lamp
biomicroscopic  and  ophthalmoscopic  observation  was
performed by Drs. Guo and Zhang. Anterior and posterior
segments of the eyes were documented by slit lamp and fundus
photography.  Flash  visual  evoked  potential  (VEP)  was
performed in one 4-year-old patient (proband in family 3).
Genomic DNA was prepared from leukocytes of peripheral
venous blood using the phenol-chloroform extracted method.
Mutation analysis: Eleven pairs of primers (Table 2) were
used  to  amplify  the  nine  coding  exons  and  the  adjacentFigure 1. Pedigrees of the six families are shown. Black filled symbols indicate patients affected with OA1 in each family. Dot-marked symbols
represent carriers. The proband is marked by arrow in each family.
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1975TABLE 1. SUMMARY OF CLINICAL FINDINGS IN AFFECTED MALES AND CARRIERS
Family
    ID#
patients Gender
Age
(yrs)
    First
symptom
      VA
(corrected)
            Iris
hypopigmentation
Fundus
a,  b,   c Nys
1 IV16 M 8 nystagmus 0.2/0.2 normal no,no, yes yes
  IV5 M 27 nystagmus 0.25/0.3 mild no,no,yes yes
  IV7 M 23 nystagmus 0.3/0.2 mild no,no,yes yes
  IV2 M 24 nystagmus 0.2/0.25 normal no,no,yes yes
  II4 M 64 nystagmus 0.4/0.2 normal no,yes,yes yes
  II2 M 77 nystagmus 0.12/0.06 normal no,yes,yes yes
  IV11 M 11 nystagmus 0.3/0.3 normal no,no,yes yes
  IV12 M 9 nystagmus 0.2/0.12 normal no,no,yes yes
2 III3 M 4 poor VA 0.1/0.1 mild ND yes
  III1 M 6 poor VA 0.2/0.2 obvious no,no,yes yes
3 IV1 M 4 poor VA ND mild no,no,yes yes
4 IV1 M 7 nystagmus 0.2/0.2 mild no,yes,yes yes
5 II1 M 12 nystagmus 0.2/0.2 normal no,no,yes yes
  II2 M 7 nystagmus 0.2/0.3 normal no,no,yes yes
6 IV5 M 4 nystagmus ND mild no,yes,yes yes
 Carriers
1 III13 F 38 NA 0.8/1.0 normal no,no,no NA
  III7 F 41 NA 0.8/1.0 normal no,no,no NA
  III8 F 36 NA 1.0/1.0 normal no,no,no NA
  III2 F 50 NA 1.0/1.0 normal no,no,no NA
3 III6 F 31 NA 1.2/1.2 mild no,yes,no NA
4 III3 F 33 NA 1.0/1.0 mild no,yes,no NA
6 III6 F 31 NA 1.0/1.0 normal no,yes,no NA
Clinical characteristics including gender, age, first symptom, visual acuity, iris, and fundus hypopigmentation form 15 OA1
patients  and 7 carriers were conclude in this table. Abbreviations: albinotic fundus (a); hypopigmentation (b); foveal hypoplasia
(c); not determined (ND); not applicable (NA), visual acuity(VA); nystagmus (Nys).
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intronic sequences of GPR143 (NCBI human genome build
36.2, GeneID 4935, NC_000023.9 for gDNA, NM_000273
for mRNA, NP_000264 for protein). Sequence analysis was
performed  as  previously  described  [18].  The  numbering
system of the nucleotides for 404 amino acids, but not 424,
was used for mutation description as previously described
[19] (see in “In silico analysis” part).
Any variations detected, except for two large intragenic
deletions, were further evaluated in available family members
as  well  as  in  100  Chinese  normal  male  controls  using
heteroduplex-single  strand  conformation  polymorphism
(SSCP)  analysis,  as  previously  described  [20].  Three
additional pairs of primers (Table 2, available on request)
[21]  were  synthesized  for  heteroduplex-SSCP  analysis  of
exons 1, 5, and 7.
In family 5, no PCR products were produced for the DNA
fragments  encompassing  exons  2  and  3  of  GPR143,
suggesting a deletion in this region. To define the boundaries
of the deletion, we designed a series of primer pairs based on
sequences  between  exons  1  and  4  to  amplify  junctional
fragments harboring the deletion. The deletion boundary was
finally identified using the primer pairs shown in Table 2
(FAM5). In family 6, no PCR product was detected for exon
8. We used the same technique to find the deletion boundary
with the primer pairs FAM6 shown in Table 2.
In silico analysis: Direct sequencing of the PCR products was
performed with an ABI BigDye Terminator Cycle Sequencing
Kit v3.1 (ABI Applied Biosystems, Foster City, CA) using an
ABI3100 Genetic Analyzer. Sequencing results from patients
as  well  as  GPR143  consensus  sequences  from  the  NCBI
human genome database (NM_000273) were imported into
the SeqManII program of the Lasergene package (DNAStar
Inc., Madison, WI) to identify variations. Each mutation was
confirmed by bidirectional sequencing. Mutation descriptions
followed  the  nomenclature  recommended  by  the  Human
Genomic Variation Society (HGVS). To evaluate the splice
site mutation, we used the Automated Splice Site Analysis
(ASSA) server [22] to analyze the possible effects of this kind
of mutation.
RESULTS
Clinical phenotype: The clinical characteristics of OA1 in
Chinese individuals are described as in Table 1 and Figure 2
and Figure 3. Table 1 shows the gender, age and clinical
characteristics of the 15 patients and 7 carriers from the six
families. Figure 2 and Figure 3 show some of the patients and
carriers′ iris and fundus image respectively.
Reduced  visual  acuity  and  nystagmus—All  OA1
patients who came to our ophthalmic center had nystagmus
and poor visual acuity as a first symptom. The nystagmus was
present since birth, and corrected visual acuity (VA) wasTABLE 2. PRIMERS FOR AMPLIFYING AND SEQUENCING GPR143 GENOMIC SEGMENTS.
Exon Forward primer (5′- 3′) Reverse primer (5′- 3′)
Product size
(bp)
Annealing
temperature (°C)
1A CTCCTCCGCCCGCCCAAGCATCAC CCCAGGCAGCCGAGAAGGTC 464 68
1B CCGCGCCTAGGGACCTTCTGCT AACCCGCGGGCCTCTCGTCCTCAC 399 70
2 CTTTCTTCCTTTTCCCTCCTTGTC GTTTGCTGCTGCTGCGATTTG 360 58
3 CACGTGCGGCTTCCTGAC TTGGCCTCTTATAAAAATGA 385 56
4 GGGCTTTCCTCTGTGTACATTTTC CCCTGAGACAACGGCCTAACC 334 60
5 GCATTTCCCTTTTTGTTCTCATCC AGGCCTGCACATTTTCATTTATTG 406 58
6 TTGCTTCCTGCCCCTCTGG ACTTGCTCCCCTGTCCTCTGT 400 60
7 TGCACCTGGCCCTCTTAGTTTC TCAGGAGGCCAAGACAGAGGAT 441 60
8A AAACCAACCCACCAACCAGTCAAC GCATGCTCAGGGCTTCGTCA 395 60
8B CCAGCCCAGGGATTTCTCTT ACCCCGCCATGCACAGGAC 329 60
9 AGCTGATGACAAACCTGCTAG CCCTTTCTCCTATCCTAAAG 330 58
FAM5 CCTAGGGACCGGATGGGACAAC CTCGCCAACAGTTACACAGCTC 487 60
FAM6 GTCCCCTTTCTTCCCTTCTCTACT GTGGTGTTTGTCTTTGGTTTTGTG 297 60
SSCP-1 AGCCACGCAGCTCGTGCTGAGCTTCCA
GCC
CCCAGGCGCTGATCAGATTCCAACCCG
CGG
250 70
SSCP-2 CATCCTCTTATCTTGACTTCC CCCAGAGAGCTTCCCTAGT 224 58
SSCP-3 CATGTTCTCTTTACCTGCTGC AGTGAGACCTTGTCTCTGAAG 227 56
Listed are primer sequences, sizes of PCR products, and annealing temperature used for the amplification. Primers 1-9 were
used  to amplify and sequence the GPR143 genimic segments. Primers FAM5 and FAM6 were used to detect the deletion
boundaries in families 5 and 6, respectively. Primers SSCP-1  to 3 were used to amplify exons 1, 5, and 7 for heterduplex-SSCP
analysis.
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between 0.1–0.3. No VA data were obtained for families 3 and
6  because  the  patients  were  not  old  enough  (Table  1)  to
cooperate with the examination. Flash VEP was performed
for the family 3 proband, and no abnormalities were observed.
The carriers did not show any symptoms, and their VA was
normal (Table 1). All participants studied had normal skin and
hair.
Iris  hypopigmentation—This  study  examined  15
Chinese OA1 patients. Compared with normal individuals
(Figure  2A),  only  one  patient  had  obvious  iris
hypopigmentation (Figure 2B). Six patients exhibited mild
peripheral iris hypopigmentation, as shown in Figure 2C, and
eight patients had no abnormalities. Of the OA1 carriers, two
exhibited mild peripheral iris hypopigmentation that could
easily have been overlooked (Figure 2D), while the other
carriers exhibited iris pigmentation that was similar to that in
normal individuals.
Hypopigmentation  in  the  fundus  and  foveal
hypoplasia—This study examined the fundi of 13 patients'.
Compared with normal individuals (Figure 3A), eight patients
had  normal  pigmentation  Figure  3B,  three  had  mild
hypopigmentation, and only two exhibited an albinotic fundus
(Figure 3C). However, all of the patients had severe foveal
hypoplasia (Table 1). In the proband of family 1 (Figure 3B),
there  was  no  typical  albinotic  fundus,  and  the  fundus
pigmentation had no abnormalities compared with normal
individuals (Figure 3A). The only sign of the disease we
observed was foveal hypoplasia. In the proband of family 4
(Figure 3C), hypopigmentation was apparent in the posterior
of the fundus, and foveal hypoplasia was evident. Of the OA1
carriers,  some  had  pigmentary  mosaicism  in  the  retinal
pigment epithelium—for example, carrier III:3 in family 4
(Figure 3D)—while others had no hypopigmentation (Table
1).
Mutation analysis: Sequence analysis of GPR143 detected six
mutations among the six families (Table 3, Figure 1, and
Figure, 4). Each of the six families studied had one of the
following  mutations:  c.849delT  (p.Val284SerfsX15);  c.
238_240delCTC  (p.Leu80del);  c.658+1G>A;  c.353G>A
(p.Gly118Glu);  g.1103_7266del6164  (p.Gly84AlafsX65),
which  resulted  in  a  deletion  of  exons  2  and  3;  and  g.
25985_26546del562 (p.Gly296ValfsX26), which resulted in
a deletion of exon 8. Of these six, c.353G>A is a known
mutation, and the other five are novel. These mutations were
present  in  affected  hemizygous  males  and  obligate
heterozygous female carriers in the families, but were not
detected  in  unaffected  males  and  100  controls  by
heteroduplex-SSCP  analysis.  The  locations  of  the  six
mutations in GPR143 are shown in Figure 4.
The c.849delT mutation (Figure 4, Table 3) is thought to
induce a frameshift, creating a termination at codon 892. The
resulting gene product lacks about a fourth of its amino acids,
including the last transmembrane domain of the C-terminus.
The c.238_240delCTC mutation resulted in a leucine deletion
in the 80th amino acid position, and the c.353G>A mutation
resulted in a replacement of glutamic acid with glycine in theFigure  2.  Photographs  of  irises  from
normal  control,  patients,  and  carriers.
Both of eyes′ irises are presented. A is a
normal  person  whose  irises  exhibited
normal pigmentation. B shows the irises
of proband (III:3) in family 2. He is the
only one patient who had obvious iris
hypopigmentation.  Obvious
hypopigmentation is observed in both of
eyes in picture B. C is the proband (IV:
1)  of  family  4,  showing  slightly
hypopigmentation in peripheral of the
both eyes. D is carrier (III:3) in family
4. Her iris hypopigmentation is also very
mild in both of eyes.
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118th  amino  acid  positions.  The  splice  site  mutation,  c.
658+1G>A,  was  expected  to  result  in  a  loss  of  the
corresponding splice sites (Figure 4, Table 3). The ASSA
server [22] result predicted that the c.658+1G>A mutation
would  significantly  change  the  strength  of  the  splicing
acceptor  (from  9.2  bits  to  –3.6  bits)  and  would  therefore
abolish  the  natural  splice  site,  corresponding  to  an
approximately 594.6 fold decrease in the predicted affinity for
this site. Two large intragenic deletions, g.1103_7266del6164
and g.25985_26546del562, resulted in the loss of an entire
exon and produced what we believe to be a nonfunctional
protein.
DISCUSSION
In our study, we found five novel mutations and one known
mutation in GPR143 among six unrelated Chinese families
with OA1. All of the patients exhibited congenital nystagmus,
poor visual acuity, mild hypopigmentation of the iris and
fundus, and severe foveal hypoplasia.Previous studies indicate that there is a higher detection
of mutations in GPR143 in OA1 patients. Schiaffino et al.
[2] screened the entire GPR143 coding sequence and detected
mutations in one-third of patients. Schnur et al. [3] reported a
higher frequency (90%) of mutations in their OA1 patient
group. Here, our result indicate that Chinese OA1 patients also
have a high frequency of mutations in GPR143 and further
confirm that GPR143 is the major locus for OA1. Based on
the high detection of mutations in GPR143, molecular genetic
testing and prenatal diagnosis should be made available to
Chinese OA1 patients.
Of the six mutations in our OA1 patients, there were four
deletion mutations, one missense mutation, and one splice site
mutation. These mutations mainly cluster within exons 1, 2,
Figure  3.  Photographs  of  fundi  from
normal  control,  patients,  and  carriers.
Both of eyes′ fundi are presented. A is
the  fundi  from  a  normal  control.  B
shows the fundi of proband (IV:16) in
family 1. There is normal pigmentation
and severe foveal hypoplasia in both of
eyes in picture B. C presents the fundi
of proband IV:1 from family 4. There
was hypopigmentation in the posterior
of  the  fundus  and  severe  foveal
hypoplasia in both of eyes in picture C.
D shows the fundi from carrier III:3 in
family  4.  There  was  pigmentary
mosaicism  in  the  retinal  pigment
epithelium, and the fovea was normal in
both of eyes.
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1979Figure  4.  Sequencing  analysis  of  six
families  with  OA1.  The  mutant
GPR143  sequence  (left)  and
corresponding normal sequence (right)
are shown for families 1–4. The exact
mutation is labeled under each sequence
according  to  the  nomenclature
recommended  by  Human  Genomic
Variation  Society  (HGVS).  Each
mutation is marked with an arrow. In
family 5, direct sequencing image was
obtained by direct sequencing. The long
band in Family 5 including exons 2 and
3,  represents  the  large  intragenic
deletion  region,  which  encompasses
about 6,164 bp from g.1103 to g.7266 of
GPR143. In family 6, direct sequencing
image  was  obtained  by  direct
sequencing,  and  the  lower  long  band
represents the deletion from g.25985 to
g.26546  encompassing  exon  8.  The
location  of  the  six  mutations  within
GPR143 is exhibited at the bottom of the
Figure  4.  Exons  are  shown  as  open
boxes  numbered  1–9,  and  thin  lines
represent introns. The locations of the
six  mutations  found  in  this  study  are
indicated beside the exons.
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19803,  and  7  of  GPR143  (Figure  4),  and  the  locations  of  the
mutations are similar to previous studies. Large intragenic
deletion is a common mutation in GPR143. Bassi et al. [23]
found  a  diverse  prevalence  of  large  deletions  between
European (<10%) and North American (>50%) patients with
OA1.  Interestingly  we  also  found  two  large  intragenic
deletions in our OA1 patients. These results may indicate that
large intragenic deletions are also common in Chinese OA1
patients. The c.353G>A (p.Gly118Glu) mutation, resulting in
the replacement of glutamic acid with glycine at the 118th
amino  acid  position,  has  been  identified  in  Caucasian
populations [3] and patients from the Netherlands [23]. And
this is the third time to report it, the mutation appeared in
different ethnic groups indicate that c.353G>A (p.Gly118Glu)
may be a hot spot mutation. Our result also shows that Chinese
OA1 patients may have a similar spectrum of mutation in
GPR143 compared with the White group. This mutation may
therefore be a hot spot mutation in different ethnic groups. The
findings from our study show that Chinese OA1 patients may
have a similar spectrum of mutation in GPR143 compared
with the Caucasian group.
The  OA1  patients  in  our  study  exhibited  congenital
nystagmus  and  poor  visual  acuity  with  mild
hypopigmentation  of  the  iris  and  fundus.  Liu  et  al.  [12]
reported a large X-linked recessive inheritance in a Chinese
family  with  nystagmus  as  a  prominent  and  consistent
manifestation of the phenotype. None of the patients in the
family  had  the  complete  classical  phenotype  of  ocular
albinism,  and  patients  were  initially  misdiagnosed  with
congenital nystagmus. The disease gene was mapped to a
region approximately 10.6 Mb in size, flanked by DXS996
and DXS7593 on Xp22 with a significant peak multipoint
LOD score. Analysis of 21 candidate genes in the region
revealed  a  novel  p.S89F  mutation  in  the  second
transmembrane domain of GPR143.
In our OA1 patients, iris hypopigmentation ranged from
mild to normal, with the exception of one patient. It was
difficult to distinguish any differences compared to normal
individuals. Our OA1 patients showed little change in clinical
characteristics  of  the  fundus,  exhibiting  only  mild
hypopigmentation and sometimes even normal pigmentation.
Severe foveal hypoplasia was the prominent clinical feature
observed in Chinese OA1 patients, which may be a useful
criterion for distinguishing OA1 from nystagmus of unknown
cause. As hypopigmentation of the iris and fundus is not
typical among the Chinese, OA1 could easily be misdiagnosed
as  another  disease  due  to  the  presence  of  nystagmus  and
severely reduced visual acuity. Although foveal hypoplasia
may be a key indicator of OA1, unawareness of the clinical
characteristics of OA1 and lack of experience might explain
why OA1 is rarely reported in the Chinese population. Here,
we  describe  the  characteristic  signs  of  OA1  in  Chinese
patients, potentially facilitating the diagnosis of OA1 in this
population.  For  patients  presenting  with  nystagmus  and
reduced visual acuity, careful evaluation of iris color, fundus
color,  and  foveal  development  is  critical.  Furthermore,
molecular genetic testing of  GPR143 might be useful for
establishing a diagnosis of OA1.
In summary, this report identified five novel mutations
and one known mutation in GPR143 of Chinese OA1 patients.
Moreover, we examined the clinical features of Chinese OA1
patients  and  found  that  foveal  hypoplasia  may  be  a  key
indicator of OA1 in patients with nystagmus of unknown
cause.  Identification  of  mutations  in  GPR143  and  more
information regarding clinical manifestations should facilitate
early  diagnosis,  appropriate  early  therapy,  and  genetic
counseling for this disease.
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TABLE 3. GPR143 MUTATIONS IDENTIFIED IN SIX CHINESE FAMILIES WITH OA1
Patients Nucleotide change Exon/intron Effect
Family 1 c.849delT e7 p.Val284SerfsX15
Family 2 c.238_240delCTC e1 p.Leu80del
Family 3 c.658+1G>A i5 Loss of splicing acceptor
Family 4* c.353G>A e2 p.Gly118Glu
Family 5 g.1103_7266del6164 Loss of exons 2 and 3 p.Gly84AlafsX65
Family 6 g.25985_26546del562 Loss of exons 8 p.Gly296ValfsX26
Five novel and one known mutations were identified in six Chinese families. The mutation was named according to the
nomenclature  recommended by Human Genomic Variation Society (HGVS ). In the third column, i5 stands for intron 5. The
asterisk indicates that the mutation has been previously reported.
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